You Ought to Have a Look is a regular feature from the Center for the Study of Science. While this section will feature all of the areas of interest that we are emphasizing, the prominence of the climate issue is driving a tremendous amount of web traffic. Here we post a few of the best in recent days, along with our color commentary.
—
With last week’s news dominated by the debates—both in front of the American people (Trump v. Clinton) and in front of the American courts (West Virginia v. EPA)—we figured we’d highlight a couple of other stories that may have not have gotten the attention that they deserved.
First up is a piece that left us slack-jawed. “How the FDA Manipulates the Media” is an investigative journalism article Charles Seife of Scientific American that reveals a seamy world of backroom press manipulation by scientific bodies (in this case, the federal Food and Drug Administration) through a practice known as a close-hold embargo. While some organizations, including major scientific journals like Science and Nature, employ an embargo system that allows some members of the press access to articles before they are officially “published” so that they can prepare news stories, the only condition is that no one releases the story before a set date. This is why a bunch of news stories, all covering the same piece of scientific information, all hit the airwaves/intertubes at the same time. While this type of embargo is a bit unfair to anyone who perhaps wants to comment on the story but is blindsided by it – the procedure only biased by the well-known predilections of the mainstream press. However, the close-hold embargo is an (almost mythical) horse of a different color. Its intent is to generate loads of press, but only good press.
Here’s a taste from Scientific American:
The deal was this: NPR, along with a select group of media outlets, would get a briefing about an upcoming announcement by the U.S. Food and Drug Administration a day before anyone else. But in exchange for the scoop, NPR would have to abandon its reportorial independence. The FDA would dictate whom NPR’s reporter could and couldn’t interview.
…This kind of deal offered by the FDA—known as a close-hold embargo—is an increasingly important tool used by scientific and government agencies to control the behavior of the science press. Or so it seems. It is impossible to tell for sure because it is happening almost entirely behind the scenes. We only know about the FDA deal because of a wayward sentence inserted by an editor at the New York Times. But for that breach of secrecy, nobody outside the small clique of government officials and trusted reporters would have known that the journalists covering the agency had given up their right to do independent reporting.
Documents obtained by Scientific American through Freedom of Information Act requests now paint a disturbing picture of the tactics that are used to control the science press. For example, the FDA assures the public that it is committed to transparency, but the documents show that, privately, the agency denies many reporters access—including ones from major outlets such as Fox News—and even deceives them with half-truths to handicap them in their pursuit of a story. At the same time, the FDA cultivates a coterie of journalists whom it keeps in line with threats. And the agency has made it a practice to demand total control over whom reporters can and can’t talk to until after the news has broken, deaf to protests by journalistic associations and media ethicists and in violation of its own written policies.
By using close-hold embargoes and other methods, the FDA, like other sources of scientific information, are gaining control of journalists who are supposed to keep an eye on those institutions. The watchdogs are being turned into lapdogs. “Journalists have ceded the power to the scientific establishment,” says Vincent Kiernan, a science journalist and dean at George Mason University.
And if you think this taste is bad, the whole article will make you ill. Sickening, but eye-opening. Perhaps take an alka seltzer first, but you really ought to have a look.